Establishment Labs (NASDAQ:ESTA) Trading Up 10.1% – Still a Buy?

Establishment Labs Holdings Inc. (NASDAQ:ESTA)’s stock price traded up 10.1% on Wednesday . The stock traded as high as $36.61 and last traded at $36.51. 522,421 shares were traded during trading, a decline of 50% from the average session volume of 1,049,284 shares. The stock had previously closed at $33.15.

Analysts Set New Price Targets

Several research analysts have recently issued reports on ESTA shares. BTIG Research upped their price objective on Establishment Labs from $62.00 to $65.00 and gave the company a “buy” rating in a research note on Monday, October 14th. Citigroup upped their price target on shares of Establishment Labs from $45.00 to $50.00 and gave the company a “neutral” rating in a research report on Tuesday, October 1st. Finally, Stephens raised shares of Establishment Labs to a “strong-buy” rating in a research note on Monday, December 2nd. One investment analyst has rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Buy” and an average price target of $60.60.

Establishment Labs Price Performance

The firm has a market capitalization of $967.68 million, a P/E ratio of -13.40 and a beta of 1.15. The company has a fifty day moving average of $43.20 and a 200 day moving average of $43.47. The company has a debt-to-equity ratio of 5.94, a current ratio of 3.62 and a quick ratio of 2.29.

Institutional Investors Weigh In On Establishment Labs

Institutional investors have recently modified their holdings of the company. Hood River Capital Management LLC acquired a new position in Establishment Labs in the second quarter valued at $43,000. Point72 Asia Singapore Pte. Ltd. bought a new position in shares of Establishment Labs in the 3rd quarter worth about $127,000. Nkcfo LLC bought a new position in shares of Establishment Labs in the 2nd quarter worth about $227,000. Black Swift Group LLC acquired a new position in shares of Establishment Labs in the 3rd quarter valued at about $312,000. Finally, Verition Fund Management LLC boosted its position in shares of Establishment Labs by 22.8% during the 3rd quarter. Verition Fund Management LLC now owns 9,400 shares of the company’s stock valued at $407,000 after purchasing an additional 1,746 shares in the last quarter. 72.91% of the stock is owned by institutional investors.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.